Laybutt, D Ross
< Back to all AuthorsArticle
Article
Yang, Chieh-Hsin, Ann-Onda, Danise, Lin, Xuzhu ORCID: 0000-0002-6634-256X, Fynch, Stacey, Nadarajah, Shaktypreya, Pappas, Evan G, Liu, Xin, Scott, John W ORCID: 0000-0002-1896-9798, Oakhill, Jonathan S ORCID: 0000-0002-9475-1440, Galic, Sandra ORCID: 0000-0002-7611-5619, Shi, Yanchuan, Moreno-Asso, Alba ORCID: 0000-0003-1213-2572, Smith, Cassandra ORCID: 0000-0002-2517-2824, Loudovaris, Thomas, Levinger, Itamar ORCID: 0000-0001-9194-2033, Eizirik, Decio L, Laybutt, D Ross, Herzog, Herbert ORCID: 0000-0002-1713-1029, Thomas, Helen E and Loh, Kim ORCID: 0000-0003-3781-1926 (2021) Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes. Molecular Metabolism, 55. ISSN 2212-8778
Kebede, Melkam, Favaloro, Jenny, Gunton, Jenny E, Laybutt, D Ross, Shaw, Margaret, Wong, Nicole, Fam, Barbara C, Aston-Mourney, Kathryn, Rantzau, Christian, Zulli, Anthony, Prioietto, Joseph and Andrikopoulos, Sofianos (2008) Fructose-1,6-bisphosphatase overexpression in pancreatic β-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of β-cell function. Diabetes, 57 (7). pp. 1887-1895. ISSN 0012-1797